This week in the Product Spotlight: Peptides and Proteins for Metabolic Syndrome Research

Metabolic Syndrome

Metabolic syndrome is increasingly becoming a worldwide problem. Sedentary lifestyle and diet choices contribute to the disorder.1,2 Read more in the PepTalk this week, as we look at two recent studies into metabolic syndrome. Several peptide hormones are useful in the study of metabolism. Below is a selection of Peptides International products available for metabolism research. Should your project require bulk quantities or a custom product, please contact us for a quote.

Adiponectin, Mouse Anti Human
ANT-232 (5µg, 20µg, 1000µg)
gAcrp30 Human (Globular Adiponectin Human Recombinant)
CYT-615 (5µg, 25µg, 1000µg)

Amylin (Human)
PAM-4219-v (0.5 mg vial)

ANP (Human, 1-28)
PAF-4135-s (0.1mg vial)
PAF-4135-v (0.5 mg vial)

BNP-32 (Human)
PBN-4212-v (0.5 mg vial)

Retinoic Acid Receptor Responder 2 Human Recombinant
PRO-788 5µg, 20µg, 1000µg)

FGF 21 Human
CYT-474 (5µg, 20µg, 1000µg)

Ghrelin (Human)
PGH-4372-s (0.1mg vial)
Ghrelin Human Recombinant
HOR-294 (5µg, 25µg, 1000µg)

GIP (Human)
PGR-4178-s 0.1mg vial)
PGR-4178-v (0.5mg vial)

Insulin (Human)
PIN-4088-s (0.1mg vial)
PIN-4088-v (0.5mg vial)
Insulin (Human) (recombinant)
CYT-270 (25mg, 250mg, 200mg)

Fibronectin Type III Domain Containing 5 Human Recombinant, Yeast
PRO-1663 (2µg, 10µg, 1000µg)        

Peptide-YY (PYY)
Peptide YY (Human, 3-36)
PYY-4400-v (0.5 mg vial)
Peptide YY (Dog, Mouse, Porcine, Rat, 3-36)
PYY-3726-PI (1mg, 5mg)

Plasminogen activator inhibitor-1
Plasminogen Activator Inhibitor-1 Human
ENZ-356 (2µg, 10µg, 1000µg)
Plasminogen Activator Inhibitor-1 Human Recombinant
ENZ-357 (5µg, 25µg, 1000µg)


  1. P. K. Santhekadura, et al., Biomed Pharmacother., 92, 826 (2017).

The entire archive of Peptides International Product Spotlights are available here.  The topics range from some of the most popular items we have available to those lesser known ones that still have compelling research applications.  They often are chosen due to recently published articles that feature them.  They are permanently posted here, so read at your leisure!